Infliximab and/or Azathioprine in the Treatment of Crohn's Disease-Like Complications After IPAA

[1]  S. Fine.  Adalimumab for the treatment of fistulas in patients with Crohn's disease. , 2011, Inflammatory bowel diseases.

[2]  O. Dewit,et al.  Efficacy of infliximab in refractory pouchitis and Crohn's disease‐related complications of the pouch: A Belgian case series , 2010, Inflammatory bowel diseases.

[3]  J. Goldblum,et al.  Administration of adalimumab in the treatment of Crohn’s disease of the ileal pouch , 2009, Alimentary pharmacology & therapeutics.

[4]  B. Shen.  Crohn's disease of the ileal pouch: Reality, diagnosis, and management , 2009, Inflammatory bowel diseases.

[5]  J. Church,et al.  Long-Term Outcomes With Ileal Pouch-Anal Anastomosis and Crohn's Disease: Pouch Retention and Implications of Delayed Diagnosis , 2008, Annals of surgery.

[6]  G. Liguori,et al.  Short‐term treatment with infliximab in chronic refractory pouchitis and ileitis , 2008, Alimentary pharmacology & therapeutics.

[7]  V. Fazio,et al.  Clinical Features and Quality of Life in Patients with Different Phenotypes of Crohn’s Disease of the Ileal Pouch , 2007, Diseases of the colon and rectum.

[8]  D. Larson,et al.  Results at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitis , 2007, The British journal of surgery.

[9]  P. Tekkis,et al.  Long‐term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[10]  J. Hartley,et al.  Analysis of the Outcome of Ileal Pouch-Anal Anastomosis in Patients With Crohn’s Disease , 2004, Diseases of the colon and rectum.

[11]  J. Murray,et al.  The Fate of the Ileal Pouch in Patients Developing Crohn’s Disease , 2004, Diseases of the colon and rectum.

[12]  P. Rutgeerts,et al.  Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.

[13]  W. Sandborn,et al.  Management of Crohn's disease of the ileoanal pouch with infliximab , 2003, American Journal of Gastroenterology.

[14]  A. Fichera,et al.  Long-term Functional Results After Ileal Pouch Anal Restorative Proctocolectomy for Ulcerative Colitis: A Prospective Observational Study , 2003, Annals of surgery.

[15]  H. Tulchinsky,et al.  Long-Term Failure After Restorative Proctocolectomy for Ulcerative Colitis , 2003, Annals of surgery.

[16]  R. Caprilli,et al.  Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis , 2003, Alimentary pharmacology & therapeutics.

[17]  W. Rowe,et al.  Remicade® Does Not Abolish the Need for Surgery in Fistulizing Crohn’s Disease , 2002, Diseases of the colon and rectum.

[18]  W. Sandborn,et al.  Successful management of Crohn's disease of the ileoanal pouch with infliximab. , 1999, Gastroenterology.

[19]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[20]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[21]  P. Sagar,et al.  Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease , 1996, Diseases of the colon and rectum.

[22]  G. Fick,et al.  Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. , 1995, Annals of internal medicine.